Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
CVB-D attenuates DOX-induced cardiac contractile dysfunction. (a) Representative mouse short-axis echocardiograms. Cardiac function parameters were indicated by (b) LVEDD and (c) LVESD, (d) ejection fraction, and (e) fractional shortening. versus the control group; versus the DOX group, .
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.